P. Roy Vagelos Left Merck In 1994 Because the board wouldn't change the mandatory retirement age of 65—a decision he still calls "ridiculous." Did he retire? No. In 1995 he became chairman of the board of Regeneron in Tarrytown, N.Y. It launched Eylea, a treatment for macular degeneration, in November 2011. In 2012 it sold $857 million of the drug and now has a market cap of $20 billion.
展开▼
机译:P. Roy Vagelos离开默克公司1994年,因为董事会不会更改65岁的法定退休年龄,这一决定他仍然称其为“荒谬的”。他退休了吗?否。1995年,他成为位于纽约州塔里敦的Regeneron董事会主席。该公司于2011年11月推出了治疗黄斑变性的Eylea。2012年,该药的销售额为8.57亿美元,目前的市值为200亿美元。
展开▼